Presspart confirm attendance at Drug Delivery to the Lungs (DDL) 26 Conference
Presspart, the world’s leading supplier of respiratory drug delivery components, have confirmed their attendance as a Gold sponsor at Drug Delivery to the Lungs (DDL26) in Edinburgh from the 9-11 December 2015.
DDL 25 will once again be held in the Edinburgh International Conference Centre in the Lennox suite, with Presspart’s stand being located just outside the main entrance to the conference in the Moffat area’
As in previous year’s Presspart will be exhibiting its full range of pharmaceutical components for respiratory drug delivery including metered-dose inhaler canisters, metered-dose inhaler actuators as well as pharmaceutical dispensing actuators for oral, nasal, topical and optic use.
As a Gold sponsor of the event, Presspart’s will be showcasing their range of MDI components, visitors will also be able to learn more about Presspart’s Quantum dose indicator system, as well as Presspart’s Electronic Dose Counter for metered-dose inhalers.
Presspart’s patented Quantum dose indicator for MDI’s has been developed to be a low cost, disposable dose indicator solution, ensuring patients don’t run out of their medication when they need it the most.
Over the three days, as well as the exhibition, the DDL conference will include a number of workshops focusing on a variety of topics within drug delivery to the lungs. There will also be the scientific posters for viewing, as well as plenty of opportunities to network at what is the last major exhibition for the industry before the holiday season.
DDL will run from 9-11 December at the Edinburgh International Conference Centre, with Presspart’s stand being located in the Moffat suite. For more information please visit the DDL website or contact Presspart.